ORYGEN ANTIBODIES LIMITED

Company number SC508543

Date	Type	Description	View / Download
23 Jan 2020	GAZ2	Final Gazette dissolved following liquidation	(1 page)
23 Oct 2019	LIQ13(Scot)	Final account prior to dissolution in MVL (final account attached)	(5 pages)
21 Mar 2019	AD01	Registered office address changed from Pentlands Science Park Bush Loan Penicuik EH26 0PZ United Kingdom to 60 Constitution Street Edinburgh EH6 6RR on 21 March 2019	(2 pages)
20 Mar 2019	RESOLUTIONS	Resolutions LRESSP ‐ Special resolution to wind up on 2019-03-13	(1 page)
20 Feb 2019	TM01	Termination of appointment of Keith Alan Charlton as a director on 20 February 2019	(1 page)
20 Feb 2019	TM01	Termination of appointment of Paul James Davis as a director on 20 February 2019	(1 page)
20 Feb 2019	TM01	Termination of appointment of Gillian Broadbent as a director on 20 February 2019	(1 page)
14 Jun 2018	CS01	Confirmation statement made on 31 May 2018 with no updates	(3 pages)
09 May 2018	AA	Total exemption full accounts made up to 30 September 2017	(9 pages) Download iXBRL
19 Jun 2017	CS01	Confirmation statement made on 31 May 2017 with updates	(5 pages)
23 Feb 2017	AA	Total exemption full accounts made up to 30 September 2016	(8 pages) Download iXBRL
29 Jun 2016	AR01	Annual return made up to 16 June 2016 with full list of shareholders Statement of capital on 2016-06-29 GBP 100	(6 pages)
26 Apr 2016	AA01	Current accounting period extended from 30 June 2016 to 30 September 2016	(1 page)
08 Oct 2015	AP01	Appointment of Mr Daniel Peter Janes as a director on 16 June 2015	(2 pages)
16 Jun 2015	NEWINC	Incorporation Statement of capital on 2015-06-16 GBP 100 MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)	(24 pages)